{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:54Z","timestamp":1792108854468,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,22]],"date-time":"2027-09-22T00:00:00Z","timestamp":1821571200000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017618","name":"National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases","doi-asserted-by":"publisher","award":["P30 DK120515"],"award-info":[{"award-number":["P30 DK120515"]}],"id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K23 AA-029197"],"award-info":[{"award-number":["K23 AA-029197"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cgh.2026.02.001","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:33:45Z","timestamp":1770770025000},"page":"2752-2761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-Associated Liver Disease"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4999-4627","authenticated-orcid":false,"given":"Kelly","family":"Torosian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Antonio","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleb","family":"Tesfai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Devuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawthar","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hersh","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-0942","authenticated-orcid":false,"given":"Veeral","family":"Ajmera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2026.02.001_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101499","article-title":"Alcohol-related liver disease: a global perspective","volume":"29","author":"Narro","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib3","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/apt.18473","article-title":"Alcohol-related liver disease, followed by metabolic dysfunction-associated steatotic liver disease, emerges as the fastest-growing aetiologies for primary liver cancer in the United States","volume":"61","author":"Danpanichkul","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2026.02.001_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2026.02.001_bib5","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMra2200923","article-title":"Liver transplantation","volume":"389","author":"Lucey","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.02.001_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamasurg.2021.3748","article-title":"Evaluation of early vs standard liver transplant for alcohol-associated liver disease","volume":"156","author":"Herrick-Reynolds","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.cgh.2026.02.001_bib7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2019.04.012","article-title":"Model to calculate harms and benefits of early vs delayed liver transplantation for patients with alcohol-associated hepatitis","volume":"157","author":"Lee","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.02.001_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2026.02.001_bib9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/ajt.16143","article-title":"Liver transplantation for alcoholic hepatitis in the United States: excellent outcomes with profound temporal and geographic variation in frequency","volume":"21","author":"Cotter","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cgh.2026.02.001_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2468-1253(21)00430-1","article-title":"Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study","volume":"7","author":"Louvet","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s43856-024-00649-x","article-title":"Disparities in steatosis prevalence in the United States by Race or Ethnicity according to the 2023 criteria","volume":"4","author":"D\u00edaz","year":"2024","journal-title":"Commun Med"},{"key":"10.1016\/j.cgh.2026.02.001_bib12","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease: update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.02.001_bib13","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.02.001_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib15","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41575-023-00822-y","article-title":"The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease","volume":"20","author":"D\u00edaz","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2026.02.001_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","volume":"81","author":"Marti-Aguado","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib18","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/liv.14830","article-title":"Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: a population-based study","volume":"41","author":"Pose","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2026.02.001_bib19","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.cgh.2020.11.038","article-title":"Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis","volume":"20","author":"Israelsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/jhep.2002.31782","article-title":"Risk factors of fibrosis in alcohol-induced liver disease","volume":"35","author":"Raynard","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.02.001_bib21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/gut.2010.213553","article-title":"Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study","volume":"59","author":"Stepanova","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2026.02.001_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cgh.2025.02.017","article-title":"An expert consensus Delphi panel in metabolic dysfunction- and alcohol-associated liver disease: opportunities and challenges in clinical practice","volume":"24","author":"Diaz","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/LVT.0000000000000722","article-title":"Gender disparity in access to early liver transplant among patients with alcohol associated liver disease and limited sobriety is mediated by psychosocial factors","volume":"32","author":"Cooper","year":"2026","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2026.02.001_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325673","article-title":"Differences in the incidence of cirrhosis-associated complications between MASLD, MetALD and ALD among patients with decompensated liver cirrhosis","volume":"20","author":"Buttler","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2026.02.001_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/HEP.0000000000000267","article-title":"Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis","volume":"77","author":"Hsu","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2026.02.001_bib26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/jgh.13240","article-title":"Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant","volume":"31","author":"Adams","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2026.02.001_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic dysfunction\u2013associated steatotic liver disease","volume":"393","author":"Targher","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2026.02.001_bib28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamainternmed.2025.1809","article-title":"Adverse liver outcomes, cardiovascular events, and mortality in steatotic liver disease","volume":"185","author":"Ochoa-Allemant","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2026.02.001_bib29","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.amjmed.2025.04.027","article-title":"Longitudinal clinical outcomes and mortality from steatotic liver disease: a meta-analysis","volume":"138","author":"Kim","year":"2025","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2026.02.001_bib30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2025.05.013","article-title":"Cause-specific mortality in patients with steatotic liver disease in the United States","volume":"83","author":"Ochoa-Allemant","year":"2025","journal-title":"J Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526000984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356526000984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:40:37Z","timestamp":1790066437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356526000984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1542356526000984"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2026.02.001","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiometabolic Risk Factors Impair Recompensation and Survival in Alcohol-Associated Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2026.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}